|

Posaconazole Clinical Trials

5 actively recruiting trials across 2 locations

Also known as: Noxafil

Pipeline

Phase 2: 2Phase 1/2: 2

Top Sponsors

  • Shandong Cancer Hospital and Institute1
  • Nantes University Hospital1
  • Bochud Pierre-Yves1
  • BeiGene1
  • AstraZeneca1

Indications

  • Cancer5
  • Acute Myeloid Leukemia2
  • Aspergillosis1
  • Candidiasis1
  • Fungal Infection1

Other3 trials

PTX3-targeted Antifungal Prophylaxis
N/A
Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
Phase 2
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI)
Phase 2

Duarte, California1 trial

A Study of BGB-11417 in Participants With Myeloid Malignancies

City of Hope National Medical Center

Phase 1/2

Decatur, Illinois1 trial

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.